Frank Menniti, Ph.D.

  • Chief Science Officer, MindImmune Therapeutics, Inc.
  • Adjunct Professor of Biomedical & Pharmaceutical Sciences, Ryan Research Professor of Neuroscience
  • Website

Research

  • NMDA receptor physiology and pharmacology
  • Antidepressant pharmaceuticals
  • NMDA receptor NR2B agonists in stroke, neuropathic pain, Parkinson’s disease